HomeNewsHealth & FitnessIn Charts | COVID-19 surge in India key numbers: Over 72,000 new cases reported in one day

In Charts | COVID-19 surge in India key numbers: Over 72,000 new cases reported in one day

India reported more than 72,000 COVID-19 new cases on April 1, biggest rise in 6 months. Active cases rose to 5.84 lakh mark. Over 6.51 crore vaccinations administered till date.

April 01, 2021 / 12:06 IST
Story continues below Advertisement
Image: AP
Image: AP

India’s COVID-19 case tally now above 1.22 crore with 72,330 new cases reported as per the health ministry’s April 1, 2021 update. New cases reported 35 percent increase in a single day, highest new cases reported since October 11, 2020 or in 172 days.

Story continues below Advertisement

India reported 459 new deaths (highest in 116 days or since December 6) and 40,382 new recoveries in the last 24 hours, the latest release shows. More than 6.51 crore vaccinations have been administered across India, according to the April 1 update, with 20,63,543 new vaccinations reported in a day.

Of the total vaccinations administered till date, 86 percent are recipients of their first dose while 14 percent have received the second dose. Among states, Maharashtra has administered the most 6.21 million vaccine doses, followed by Rajasthan (5.72 million) and Gujarat (5.70 million).

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show